Literature DB >> 21953935

Structural characterization of human Uch37.

Sethe E Burgie1, Craig A Bingman, Ameet B Soni, George N Phillips.   

Abstract

Uch37 is a de-ubiquitylating enzyme that is functionally linked with the 26S proteasome via Rpn13, and is essential for metazoan development. Here, we report the X-ray crystal structure of full-length human Uch37 at 2.95 Å resolution. Uch37's catalytic domain is similar to those of all UCH enzymes characterized to date. The C-terminal extension is elongated, predominantly helical and contains coiled coil interactions. Additionally, we provide an initial characterization of Uch37's oligomeric state and identify a systematic error in previous analyses of Uch37 activity. Taken together, these data provide a strong foundation for further analysis of Uch37's several functions.

Entities:  

Keywords:  UCH-L5; deubiquitylating enzymes; proteasome; protein assembly; ubiquitin; ubiquitin C-terminal hydrolase

Mesh:

Substances:

Year:  2011        PMID: 21953935      PMCID: PMC3251636          DOI: 10.1002/prot.23147

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  34 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Structural basis for the specificity of ubiquitin C-terminal hydrolases.

Authors:  S C Johnston; S M Riddle; R E Cohen; C P Hill
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

3.  Substructure search procedures for macromolecular structures.

Authors:  R W Grosse-Kunstleve; P D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-10-23

4.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

5.  Project management system for structural and functional proteomics: Sesame.

Authors:  Zsolt Zolnai; Peter T Lee; Jing Li; Michael R Chapman; Craig S Newman; George N Phillips; Ivan Rayment; Eldon L Ulrich; Brian F Volkman; John L Markley
Journal:  J Struct Funct Genomics       Date:  2003

Review 6.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

7.  Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome.

Authors:  Y A Lam; W Xu; G N DeMartino; R E Cohen
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

Review 8.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

9.  Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution.

Authors:  S C Johnston; C N Larsen; W J Cook; K D Wilkinson; C P Hill
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

10.  The unusual catalytic triad of poliovirus protease 3C.

Authors:  Zsuzsa Sárkány; László Polgár
Journal:  Biochemistry       Date:  2003-01-21       Impact factor: 3.162

View more
  24 in total

1.  Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.

Authors:  Isel Castro; Elmira Ekinci; Xuemei Huang; Hassan Ali Cheaito; Young-Hoon Ahn; Jesus Olivero-Verbel; Q Ping Dou
Journal:  J Cell Biochem       Date:  2019-04-08       Impact factor: 4.429

2.  Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15.

Authors:  Xin Wang; Pádraig D'Arcy; Thomas R Caulfield; Aneel Paulus; Kasyapa Chitta; Chitralekha Mohanty; Joachim Gullbo; Asher Chanan-Khan; Stig Linder
Journal:  Chem Biol Drug Des       Date:  2015-05-27       Impact factor: 2.817

3.  Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.

Authors:  Hongzhuang Peng; Jeremy Prokop; Jayashree Karar; Kyewon Park; Li Cao; J William Harbour; Anne M Bowcock; S Bruce Malkowicz; Mitchell Cheung; Joseph R Testa; Frank J Rauscher
Journal:  Cancer Res       Date:  2017-12-28       Impact factor: 12.701

Review 4.  Structural biology of the proteasome.

Authors:  Erik Kish-Trier; Christopher P Hill
Journal:  Annu Rev Biophys       Date:  2013-02-13       Impact factor: 12.981

5.  Structural basis for the activation and inhibition of the UCH37 deubiquitylase.

Authors:  Ryan T Vander Linden; Casey W Hemmis; Benjamin Schmitt; Ada Ndoja; Frank G Whitby; Howard Robinson; Robert E Cohen; Tingting Yao; Christopher P Hill
Journal:  Mol Cell       Date:  2015-02-19       Impact factor: 17.970

6.  Performance of MDockPP in CAPRI rounds 28-29 and 31-35 including the prediction of water-mediated interactions.

Authors:  Xianjin Xu; Liming Qiu; Chengfei Yan; Zhiwei Ma; Sam Z Grinter; Xiaoqin Zou
Journal:  Proteins       Date:  2016-12-02

7.  Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity.

Authors:  Marie E Morrow; Myung-Il Kim; Judith A Ronau; Michael J Sheedlo; Rhiannon R White; Joseph Chaney; Lake N Paul; Markus A Lill; Katerina Artavanis-Tsakonas; Chittaranjan Das
Journal:  Biochemistry       Date:  2013-05-09       Impact factor: 3.162

Review 8.  Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Authors:  Stefanie A H de Poot; Geng Tian; Daniel Finley
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 9.  Regulation of proteolysis by human deubiquitinating enzymes.

Authors:  Ziad M Eletr; Keith D Wilkinson
Journal:  Biochim Biophys Acta       Date:  2013-07-09

10.  Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.

Authors:  Michael L Nickerson; Garrett M Dancik; Kate M Im; Michael G Edwards; Sevilay Turan; Joseph Brown; Christina Ruiz-Rodriguez; Charles Owens; James C Costello; Guangwu Guo; Shirley X Tsang; Yingrui Li; Quan Zhou; Zhiming Cai; Lee E Moore; M Scott Lucia; Michael Dean; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2014-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.